首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   105312篇
  免费   7118篇
  国内免费   7185篇
  2024年   174篇
  2023年   1650篇
  2022年   2276篇
  2021年   3456篇
  2020年   3282篇
  2019年   4466篇
  2018年   3776篇
  2017年   2920篇
  2016年   2972篇
  2015年   3679篇
  2014年   6234篇
  2013年   7965篇
  2012年   5100篇
  2011年   6217篇
  2010年   4914篇
  2009年   5460篇
  2008年   5728篇
  2007年   5906篇
  2006年   5495篇
  2005年   4903篇
  2004年   4385篇
  2003年   3729篇
  2002年   3369篇
  2001年   2480篇
  2000年   1967篇
  1999年   1936篇
  1998年   1799篇
  1997年   1491篇
  1996年   1400篇
  1995年   1281篇
  1994年   1195篇
  1993年   887篇
  1992年   835篇
  1991年   696篇
  1990年   568篇
  1989年   438篇
  1988年   433篇
  1987年   381篇
  1986年   303篇
  1985年   398篇
  1984年   575篇
  1983年   395篇
  1982年   427篇
  1981年   308篇
  1980年   252篇
  1979年   230篇
  1978年   197篇
  1977年   157篇
  1976年   135篇
  1973年   115篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
141.
142.
143.
《Molecular cell》2020,77(2):228-240.e7
  1. Download : Download high-res image (127KB)
  2. Download : Download full-size image
  相似文献   
144.
《Molecular cell》2020,77(4):748-760.e9
  1. Download : Download high-res image (218KB)
  2. Download : Download full-size image
  相似文献   
145.
146.
《Molecular cell》2020,77(6):1265-1278.e7
  1. Download : Download high-res image (317KB)
  2. Download : Download full-size image
  相似文献   
147.
148.
Genistein (GEN) has been previously shown to have a proapoptotic effect on cancer cells through a p53-dependent pathway, the mechanism of which remains unclear. One of its intracellular targets, APE1, protects against apoptosis under genotoxic stress and interacts with p53. In this current study, we explored the mechanism of the proapoptotic effect of GEN by examining the APE1–p53 protein–protein interaction. We initially showed that the p53 protein level was elevated in GEN-treated human non-small lung cancer A549 cells and cervical cancer HeLa cells. By examining both protein synthesis and degradation, we found that GEN enhances p53 intracellular stability by interfering with the interaction of APE1 and p53, which provided a plausible explanation for how GEN initiates apoptosis. Furthermore, we found that the interaction between APE1 and p53 is important for the degradation of p53 and is dependent on the redox domain of APE1 by utilizing the redox domain mutant APE1 C65A. Our data suggest that the degradation of wild-type p53 is blocked when the redox domain of APE1 is masked or interrupted. Based on this evidence, we hereby report a novel mechanism of p53 degradation through an APE1-mediated, redox-dependent pathway.  相似文献   
149.
Restriction fragment length polymorphisms (RFLPs) were described for the porcine loci for β-glucosidase (GBA) and the β-polypeptide 1 of the Na+, K+-transporting ATPase (ATP1B1). Linkage analyses using a three-generation pedigree provided evidence for the assignment of ATP1B1, GBA and two microsatellite loci (S0001 and S0067) to a previously described linkage group comprising the loci for blood group L (EAL) and an anonymous microsatellite (S0097). The linear order of the six markers was determined with confidence by multipoint analyses and the length of the linkage group was estimated at 88 CM. This linkage group was assigned to pig chromosome 4 on the basis of a previous physical localization of the ATP1B1 gene. In situ hybridization data for S0001 presented in this study were consistent with a localization on chromosome 4 and suggested a regional localization to 4pl2-pl3. The present study reveals conflicting data concerning the genetic localization of the K88 loci controlling the expression of the receptors for the E. coli pilus antigens. One group has reported data suggesting a loose linkage between K88 and EAL, now mapped to chromosome 4, whereas two other groups have found linkage between K88 and the transferrin locus (TF), mapped to chromosome 13 by in situ hybridization.  相似文献   
150.
Tubulin-binding agents such as taxol, vincristine or vinblastine are well-established drugs in clinical treatment of metastatic cancer. However, because of their highly complex chemical structures, the synthesis and hence the supply issues are still quite challenging. Here we set on stage pretubulysin, a chemically accessible precursor of tubulysin that was identified as a potent microtubule-binding agent produced by myxobacteria. Although much simpler in chemical structure, pretubulysin abrogates proliferation and long-term survival as well as anchorage-independent growth, and also induces anoikis and apoptosis in invasive tumor cells equally potent to tubulysin. Moreover, pretubulysin posseses in vivo efficacy shown in a chicken chorioallantoic membrane (CAM) model with T24 bladder tumor cells, in a mouse xenograft model using MDA-MB-231 mammary cancer cells and finally in a model of lung metastasis induced by 4T1 mouse breast cancer cells. Pretubulysin induces cell death via the intrinsic apoptosis pathway by abrogating the expression of pivotal antiapoptotic proteins, namely Mcl-1 and Bcl-xL, and shows distinct chemosensitizing properties in combination with TRAIL in two- and three-dimensional cell culture models. Unraveling the underlying signaling pathways provides novel information: pretubulysin induces proteasomal degradation of Mcl-1 by activation of mitogen-activated protein kinase (especially JNK (c-Jun N-terminal kinase)) and phosphorylation of Mcl-1, which is then targeted by the SCFFbw7 E3 ubiquitin ligase complex for ubiquitination and degradation. In sum, we designate the microtubule-destabilizing compound pretubulysin as a highly promising novel agent for mono treatment and combinatory treatment of invasive cancer.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号